- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 1/36 - ExtractionSeparationPurification by a combination of two or more processes of different types
Patent holdings for IPC class C07K 1/36
Total number of patents in this class: 1145
10-year publication summary
|
64
|
63
|
83
|
87
|
99
|
118
|
86
|
83
|
72
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4492 |
67 |
| Genentech, Inc. | 4037 |
32 |
| EMD Millipore Corporation | 641 |
27 |
| Amgen Inc. | 4286 |
23 |
| Takeda Pharmaceutical Company Limited | 2710 |
19 |
| Plasma Technologies, LLC | 28 |
14 |
| Bristol-myers Squibb Company | 4793 |
13 |
| Genzyme Corporation | 1324 |
13 |
| Green Cross Corporation | 206 |
12 |
| AbbVie Biotechnology Ltd. | 181 |
11 |
| Laboratoire Francais du Fractionnement et des Biotechnologies | 295 |
10 |
| CSL Behring AG | 181 |
9 |
| Sartorius Stedim Biotech GmbH | 861 |
9 |
| Abbvie Inc. | 1819 |
8 |
| The Catholic University of America | 99 |
8 |
| Agency for Science, Technology and Research | 3662 |
7 |
| Green Cross Holdings Corporation | 53 |
7 |
| Cytiva BioProcess R&D AB | 313 |
7 |
| F. Hoffmann-La Roche AG | 7890 |
6 |
| Hoffmann-La Roche Inc. | 3589 |
6 |
| Other owners | 837 |